October 1, 2021
ECRI partners with FDA on safety of materials in medical devices
Editor's Note
ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials.
ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients over time.
The first four reports are available now on FDA.gov: magnesium, polypropylene, polyurethanes, and siloxanes.
Free Daily News
- US launches tariff investigations into medical supplies and devices, raising stakes for healthcare supply chain
- AORN: Periop patient ambassadors transform communication, outcomes in surgical care
- Government shutdown squeezes military medicine, halts NIH research, cuts CDC operations
- AI is transforming nursing practice but demands stronger ethics, training
- Government shutdown stalls healthcare access, freezes Medicare telehealth, hospital-at-home services
- ACS launches hospital search tool to spotlight surgical quality
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement